Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990-2021.

ABSTRACT:

Background

High body mass index (BMI) is a well-established risk factor for ovarian and uterine cancer. However, the global, regional, and national burden of these cancers attributable to high BMI remains underexplored. This study quantifies the trends and disparities in the burden of ovarian and uterine cancer due to high BMI from 1990 to 2021 using the Global Burden of Disease (GBD) 2021 dataset.

Methods

We extracted data from GBD 2021 to estimate the mortality, incidence, and disability-adjusted life years (DALYs) attributable to high BMI for ovarian and uterine cancer across different locations and time periods. We focused on the burden of ovarian and uterine cancers among women aged 20-49. Age-standardized rates (ASRs) were calculated, and temporal trends were analyzed

SUBMITTER: Han H 

PROVIDER: S-EPMC12580100 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature